Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is ¥6,978.83, with a 24-hour trading volume of ¥10.53B. The asset's market cap is ¥6.24T, after moving -0.96% in the last day.
Tokenized Eli Lilly And Co is trading at ¥6,990.98, with a tokenized market cap of ¥37.24M and a 24-hour trading volume of ¥30.25M. The tokenized asset has moved -0.71% in the past 24 hours.